|
G |
ABCB11 |
ATP binding cassette subfamily B member 11 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of ABCB11 mRNA |
CTD |
PMID:27090119 |
|
NCBI chr 2:168,915,468...169,031,396
Ensembl chr 2:168,915,498...169,031,324
|
|
G |
ABCC2 |
ATP binding cassette subfamily C member 2 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of ABCC2 mRNA |
CTD |
PMID:27090119 |
|
NCBI chr10:99,782,602...99,853,741
Ensembl chr10:99,782,640...99,852,594
|
|
G |
ACACA |
acetyl-CoA carboxylase alpha |
increases phosphorylation multiple interactions increases expression |
EXP ISO |
AICA ribonucleotide results in increased phosphorylation of ACACA protein AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of and results in decreased phosphorylation of ACACA protein]; AICA ribonucleotide results in decreased expression of and results in increased phosphorylation of ACACA protein AICA ribonucleotide results in increased expression of ACACA protein modified form |
CTD |
PMID:15297373 PMID:16020477 PMID:16873680 PMID:20080969 PMID:25743752 PMID:27103584 |
|
NCBI chr17:37,084,992...37,406,836
Ensembl chr17:37,084,992...37,406,836
|
|
G |
ACACB |
acetyl-CoA carboxylase beta |
increases phosphorylation |
EXP |
AICA ribonucleotide results in increased phosphorylation of ACACB protein |
CTD |
PMID:16873680 |
|
NCBI chr12:109,112,666...109,268,226
Ensembl chr12:109,116,595...109,268,226
|
|
G |
ACADM |
acyl-CoA dehydrogenase medium chain |
multiple interactions increases expression |
ISO EXP |
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of ACADM mRNA] AICA ribonucleotide results in increased expression of ACADM mRNA; AICA ribonucleotide results in increased expression of ACADM protein |
CTD |
PMID:19699196 PMID:25743752 |
|
NCBI chr 1:75,724,709...75,763,679
Ensembl chr 1:75,724,347...75,787,575 Ensembl chr 1:75,724,347...75,787,575
|
|
G |
ACTA2 |
actin alpha 2, smooth muscle |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein] |
CTD |
PMID:27688165 |
|
NCBI chr10:88,935,074...88,991,397
Ensembl chr10:88,935,074...88,991,339
|
|
G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
increases expression multiple interactions |
ISO |
AICA ribonucleotide results in increased expression of ADIPOQ protein AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ADIPOQ mRNA] |
CTD |
PMID:20980258 PMID:25108154 |
|
NCBI chr 3:186,842,710...186,858,463
Ensembl chr 3:186,842,704...186,858,463
|
|
G |
AKT1 |
AKT serine/threonine kinase 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in decreased oxidation of Fatty Acids]; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased phosphorylation of EIF4EBP1 protein]; AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased susceptibility to Glucose deficiency]; PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]] |
CTD |
PMID:15806154 |
|
NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
|
|
G |
APP |
amyloid beta precursor protein |
decreases expression |
EXP |
AICA ribonucleotide results in decreased expression of APP protein modified form |
CTD |
PMID:20080969 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,550...26,171,128
|
|
G |
ARG1 |
arginase 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of ARG1 mRNA] |
CTD |
PMID:25108154 |
|
NCBI chr 6:131,573,226...131,584,329
Ensembl chr 6:131,470,832...131,584,332
|
|
G |
ATG5 |
autophagy related 5 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [Ethanol results in decreased expression of ATG5 protein] |
CTD |
PMID:24582693 |
|
NCBI chr 6:106,184,476...106,325,789
Ensembl chr 6:106,045,423...106,325,791
|
|
G |
BECN1 |
beclin 1 |
increases expression multiple interactions |
ISO |
AICA ribonucleotide results in increased expression of BECN1 protein AICA ribonucleotide promotes the reaction [4-nonylphenol results in increased expression of BECN1 protein] |
CTD |
PMID:28041982 |
|
NCBI chr17:42,810,132...42,824,282
Ensembl chr17:42,810,134...42,833,350
|
|
G |
CASP3 |
caspase 3 |
increases activity multiple interactions |
ISO EXP |
AICA ribonucleotide results in increased activity of CASP3 protein AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP3 protein] |
CTD |
PMID:16469385 PMID:21906609 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,649,509
|
|
G |
CASP7 |
caspase 7 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [sunitinib results in increased cleavage of CASP7 protein] |
CTD |
PMID:21906609 |
|
NCBI chr10:113,679,194...113,730,909
Ensembl chr10:113,679,162...113,730,907
|
|
G |
CASP9 |
caspase 9 |
increases activity |
ISO |
AICA ribonucleotide results in increased activity of CASP9 protein |
CTD |
PMID:16469385 |
|
NCBI chr 1:15,491,401...15,524,912
Ensembl chr 1:15,490,832...15,526,534
|
|
G |
CAT |
catalase |
multiple interactions increases expression |
EXP |
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA] AICA ribonucleotide results in increased expression of CAT mRNA; AICA ribonucleotide results in increased expression of CAT protein |
CTD |
PMID:25065674 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCL2 |
C-C motif chemokine ligand 2 |
multiple interactions decreases expression |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL2 mRNA] AICA ribonucleotide results in decreased expression of CCL2 mRNA AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of CCL2 mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of CCL2 mRNA] |
CTD |
PMID:24465016 PMID:25108154 |
|
NCBI chr17:34,255,285...34,257,203
Ensembl chr17:34,255,218...34,257,203
|
|
G |
CCL3 |
C-C motif chemokine ligand 3 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CCL3 mRNA] |
CTD |
PMID:21745629 |
|
NCBI chr17:36,088,256...36,090,143
Ensembl chr17:36,088,256...36,090,169
|
|
G |
CCNA2 |
cyclin A2 |
multiple interactions decreases expression |
EXP |
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR] AICA ribonucleotide results in decreased expression of CCNA2 mRNA; AICA ribonucleotide results in decreased expression of CCNA2 protein |
CTD |
PMID:12730239 |
|
NCBI chr 4:121,816,444...121,823,883
Ensembl chr 4:121,816,444...121,823,883 Ensembl chr 4:121,816,444...121,823,883
|
|
G |
CCNB1 |
cyclin B1 |
multiple interactions decreases expression |
EXP |
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] AICA ribonucleotide results in decreased expression of CCNB1 mRNA; AICA ribonucleotide results in decreased expression of CCNB1 protein |
CTD |
PMID:12730239 |
|
NCBI chr 5:69,167,150...69,178,245
Ensembl chr 5:69,167,135...69,178,245
|
|
G |
CD36 |
CD36 molecule |
multiple interactions |
EXP |
AICA ribonucleotide results in increased expression of and affects the localization of CD36 protein |
CTD |
PMID:28038998 |
|
NCBI chr 7:80,602,207...80,679,277
Ensembl chr 7:80,369,575...80,679,277
|
|
G |
CEBPA |
CCAAT enhancer binding protein alpha |
decreases expression multiple interactions |
ISO |
AICA ribonucleotide results in decreased expression of CEBPA protein AICA ribonucleotide inhibits the reaction [fipronil results in increased expression of CEBPA protein] |
CTD |
PMID:27103584 |
|
NCBI chr19:33,299,934...33,302,564
Ensembl chr19:33,299,934...33,302,534
|
|
G |
CEBPB |
CCAAT enhancer binding protein beta |
increases phosphorylation |
EXP |
AICA ribonucleotide results in increased phosphorylation of CEBPB protein |
CTD |
PMID:28038998 |
|
NCBI chr20:50,190,583...50,192,690
Ensembl chr20:50,190,830...50,192,668
|
|
G |
CFTR |
CF transmembrane conductance regulator |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Colforsin results in increased activity of CFTR protein] |
CTD |
PMID:12519745 |
|
NCBI chr 7:117,480,025...117,668,665
Ensembl chr 7:117,287,120...117,715,971 Ensembl chr 7:117,287,120...117,715,971
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein] |
CTD |
PMID:27688165 |
|
NCBI chr17:50,184,096...50,201,649
Ensembl chr17:50,183,289...50,201,632 Ensembl chr17:50,183,289...50,201,632
|
|
G |
CPT1A |
carnitine palmitoyltransferase 1A |
increases expression multiple interactions |
EXP ISO |
AICA ribonucleotide results in increased expression of CPT1A mRNA; AICA ribonucleotide results in increased expression of CPT1A protein dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of CPT1A mRNA] |
CTD |
PMID:24465016 PMID:25743752 |
|
NCBI chr11:68,754,620...68,844,410
Ensembl chr11:68,754,620...68,844,410
|
|
G |
CPT1B |
carnitine palmitoyltransferase 1B |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of CPT1B protein] |
CTD |
PMID:19699196 |
|
NCBI chr22:50,568,861...50,578,612
Ensembl chr22:50,568,861...50,578,465
|
|
G |
CTNNB1 |
catenin beta 1 |
multiple interactions increases expression |
ISO |
[AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA; [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 protein; AICA ribonucleotide inhibits the reaction [[HDAC5 protein binds to MEF2 protein] which binds to CTNNB1 promoter]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 mRNA]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 protein] AICA ribonucleotide results in increased expression of CTNNB1 mRNA; AICA ribonucleotide results in increased expression of CTNNB1 protein |
CTD |
PMID:21454484 |
|
NCBI chr 3:41,199,422...41,240,445
Ensembl chr 3:41,194,741...41,260,096
|
|
G |
CXCL8 |
C-X-C motif chemokine ligand 8 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of CXCL8 mRNA] |
CTD |
PMID:21745629 |
|
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,541...73,743,716
|
|
G |
CYBA |
cytochrome b-245 alpha chain |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBA protein] |
CTD |
PMID:21195169 |
|
NCBI chr16:88,643,289...88,651,079
Ensembl chr16:88,643,289...88,651,054
|
|
G |
CYBB |
cytochrome b-245 beta chain |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of CYBB protein] |
CTD |
PMID:21195169 |
|
NCBI chr X:37,780,059...37,813,461
Ensembl chr X:37,780,059...37,813,461 Ensembl chr X:37,780,059...37,813,461
|
|
G |
CYP4F2 |
cytochrome P450 family 4 subfamily F member 2 |
multiple interactions increases expression |
EXP |
dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA]; PRKAA1 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] |
CTD |
PMID:21205922 |
|
NCBI chr19:15,878,023...15,898,074
Ensembl chr19:15,878,023...15,898,077
|
|
G |
EGFR |
epidermal growth factor receptor |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [EGFR protein results in increased import of Deoxyglucose] |
CTD |
PMID:19625624 |
|
NCBI chr 7:55,019,017...55,211,628
Ensembl chr 7:55,019,017...55,211,628
|
|
G |
EIF2S1 |
eukaryotic translation initiation factor 2 subunit alpha |
decreases phosphorylation |
EXP |
AICA ribonucleotide results in decreased phosphorylation of EIF2S1 protein |
CTD |
PMID:22898769 |
|
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,151...67,386,516 Ensembl chr14:67,360,151...67,386,516
|
|
G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
multiple interactions decreases phosphorylation |
ISO |
AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form results in increased phosphorylation of EIF4EBP1 protein] AICA ribonucleotide results in decreased phosphorylation of EIF4EBP1 protein AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased phosphorylation of EIF4EBP1 protein] |
CTD |
PMID:15806154 PMID:21195169 PMID:28041982 |
|
NCBI chr 8:38,030,534...38,060,365
Ensembl chr 8:38,030,534...38,060,365
|
|
G |
ELAVL1 |
ELAV like RNA binding protein 1 |
multiple interactions decreases localization |
EXP |
AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNA2 3' UTR]; AICA ribonucleotide inhibits the reaction [ELAVL1 protein binds to CCNB1 3' UTR] AICA ribonucleotide results in decreased localization of ELAVL1 protein |
CTD |
PMID:12730239 |
|
NCBI chr19:7,958,573...8,005,641
Ensembl chr19:7,958,573...8,005,659
|
|
G |
FOXO1 |
forkhead box O1 |
multiple interactions increases expression increases phosphorylation increases activity |
EXP |
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of CAT mRNA]; AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of SOD2 mRNA] AICA ribonucleotide results in increased expression of FOXO1 protein AICA ribonucleotide results in increased phosphorylation of FOXO1 protein AICA ribonucleotide results in increased activity of FOXO1 protein |
CTD |
PMID:25065674 |
|
NCBI chr13:40,555,667...40,666,641
Ensembl chr13:40,555,667...40,666,641 Ensembl chr13:40,555,667...40,666,641
|
|
G |
FSHB |
follicle stimulating hormone subunit beta |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [FSHB protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:16020477 |
|
NCBI chr11:30,231,014...30,235,194
Ensembl chr11:30,231,016...30,235,261 Ensembl chr11:30,231,016...30,235,261
|
|
G |
G6PC1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of G6PC1 mRNA |
CTD |
PMID:19664596 |
|
NCBI chr17:42,900,799...42,914,438
Ensembl chr17:42,900,797...42,914,438
|
|
G |
GPR68 |
G protein-coupled receptor 68 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; AICA ribonucleotide inhibits the reaction [TNF protein results in increased expression of GPR68 mRNA] |
CTD |
PMID:28174749 |
|
NCBI chr14:91,232,532...91,264,581
Ensembl chr14:91,232,532...91,253,925
|
|
G |
GRB2 |
growth factor receptor bound protein 2 |
multiple interactions |
ISO |
GRB2 protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein] |
CTD |
PMID:11978788 |
|
NCBI chr17:75,318,076...75,405,678
Ensembl chr17:75,318,076...75,405,709
|
|
G |
GSTK1 |
glutathione S-transferase kappa 1 |
increases expression |
ISO |
AICA ribonucleotide results in increased expression of GSTK1 protein |
CTD |
PMID:20980258 |
|
NCBI chr 7:143,263,441...143,269,115
Ensembl chr 7:143,244,093...143,270,854
|
|
G |
HDAC5 |
histone deacetylase 5 |
multiple interactions increases phosphorylation |
ISO |
[AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 mRNA; [AICA ribonucleotide results in increased phosphorylation of HDAC5 protein] which results in increased expression of CTNNB1 protein; AICA ribonucleotide inhibits the reaction [[HDAC5 protein binds to MEF2 protein] which binds to CTNNB1 promoter] |
CTD |
PMID:21454484 |
|
NCBI chr17:44,076,753...44,123,651
Ensembl chr17:44,076,746...44,123,702
|
|
G |
HNF4A |
hepatocyte nuclear factor 4 alpha |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of HNF4A mRNA |
CTD |
PMID:24428821 |
|
NCBI chr20:44,355,699...44,434,596
Ensembl chr20:44,355,700...44,434,596
|
|
G |
HSD3B1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of HSD3B1 mRNA; AICA ribonucleotide results in decreased expression of HSD3B1 protein |
CTD |
PMID:16020477 |
|
NCBI chr 1:119,507,203...119,515,058
Ensembl chr 1:119,507,198...119,515,054
|
|
G |
IGF1 |
insulin like growth factor 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] |
CTD |
PMID:16020477 |
|
NCBI chr12:102,395,860...102,481,839
Ensembl chr12:102,395,874...102,481,744
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions decreases expression |
ISO |
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of IL1B mRNA] |
CTD |
PMID:24465016 |
|
NCBI chr 2:112,829,751...112,836,843
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL6 |
interleukin 6 |
multiple interactions decreases expression |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of IL6 mRNA] AICA ribonucleotide results in decreased expression of IL6 mRNA AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in decreased expression of IL6 mRNA] |
CTD |
PMID:24465016 PMID:25108154 |
|
NCBI chr 7:22,725,889...22,732,002
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
INSR |
insulin receptor |
multiple interactions decreases activity decreases expression |
EXP |
5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased activity of INSR promoter]; 5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR mRNA]; 5'-amino-5'-deoxyadenosine inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR protein]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased activity of INSR promoter]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR mRNA]; Dipyridamole inhibits the reaction [AICA ribonucleotide results in decreased expression of INSR protein] AICA ribonucleotide results in decreased expression of INSR mRNA; AICA ribonucleotide results in decreased expression of INSR protein |
CTD |
PMID:15694368 |
|
NCBI chr19:7,112,257...7,294,414
Ensembl chr19:7,112,255...7,294,414
|
|
G |
KCNJ11 |
potassium inwardly rectifying channel subfamily J member 11 |
affects response to substance |
ISO |
KCNJ11 protein affects the susceptibility to AICA ribonucleotide |
CTD |
PMID:24498880 |
|
NCBI chr11:17,385,246...17,389,346
Ensembl chr11:17,385,859...17,389,331 Ensembl chr11:17,385,859...17,389,331
|
|
G |
KLF15 |
Kruppel like factor 15 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of KLF15 mRNA |
CTD |
PMID:24428821 |
|
NCBI chr 3:126,288,121...126,357,408
Ensembl chr 3:126,342,635...126,357,408
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO EXP |
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK1 protein]; AICA ribonucleotide inhibits the reaction [IGF1 protein results in increased phosphorylation of MAPK1 protein] AICA ribonucleotide results in increased phosphorylation of MAPK1 protein AICA ribonucleotide results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:16020477 PMID:28038998 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,754,500...21,867,680 Ensembl chr22:21,754,500...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions increases phosphorylation decreases phosphorylation |
ISO EXP |
AICA ribonucleotide inhibits the reaction [[IGF1 protein co-treated with FSHB protein] results in increased phosphorylation of MAPK3 protein]; AICA ribonucleotide inhibits the reaction [FSHB protein results in increased phosphorylation of MAPK3 protein]; MAPK3 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of MAPK3 protein] AICA ribonucleotide results in increased phosphorylation of MAPK3 protein AICA ribonucleotide results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:11978788 PMID:16020477 PMID:28038998 |
|
NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MFN1 |
mitofusin 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of MFN1 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of MFN1 protein] |
CTD |
PMID:27792760 |
|
NCBI chr 3:179,347,709...179,394,936
Ensembl chr 3:179,347,709...179,394,936
|
|
G |
MFN2 |
mitofusin 2 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of MFN2 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of MFN2 protein] |
CTD |
PMID:27792760 |
|
NCBI chr 1:11,980,215...12,013,508
Ensembl chr 1:11,980,181...12,015,211 Ensembl chr 1:11,980,181...12,015,211
|
|
G |
MMP13 |
matrix metallopeptidase 13 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein] |
CTD |
PMID:27688165 |
|
NCBI chr11:102,942,995...102,955,732
Ensembl chr11:102,942,995...102,955,732
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
decreases activity |
EXP |
AICA ribonucleotide results in decreased activity of MMP2 protein |
CTD |
PMID:20590612 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MMP9 |
matrix metallopeptidase 9 |
decreases activity |
EXP |
AICA ribonucleotide results in decreased activity of MMP9 protein |
CTD |
PMID:20590612 |
|
NCBI chr20:46,008,908...46,016,561
Ensembl chr20:46,008,908...46,016,561
|
|
G |
MTOR |
mechanistic target of rapamycin kinase |
decreases activity decreases phosphorylation multiple interactions |
EXP ISO |
AICA ribonucleotide results in decreased activity of MTOR protein AICA ribonucleotide results in decreased phosphorylation of MTOR protein AICA ribonucleotide promotes the reaction [4-nonylphenol results in decreased phosphorylation of MTOR protein] AICA ribonucleotide promotes the reaction [Cadmium results in decreased phosphorylation of MTOR protein] |
CTD |
PMID:19625624 PMID:21767558 PMID:27363783 PMID:28041982 |
|
NCBI chr 1:11,106,535...11,273,497
Ensembl chr 1:11,106,535...11,262,551
|
|
G |
NCF1 |
neutrophil cytosolic factor 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF1 protein] |
CTD |
PMID:21195169 |
|
NCBI chr 7:74,773,962...74,789,376
Ensembl chr 7:74,773,962...74,789,376
|
|
G |
NCF2 |
neutrophil cytosolic factor 2 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF2 protein] |
CTD |
PMID:21195169 |
|
NCBI chr 1:183,555,562...183,590,914
Ensembl chr 1:183,555,563...183,590,876 Ensembl chr 1:183,555,563...183,590,876
|
|
G |
NCF4 |
neutrophil cytosolic factor 4 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of NCF4 protein] |
CTD |
PMID:21195169 |
|
NCBI chr22:36,861,006...36,878,015
Ensembl chr22:36,860,988...36,878,017
|
|
G |
NFKB1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased localization of NFKB1 protein] |
CTD |
PMID:22025971 |
|
NCBI chr 4:102,501,266...102,617,302
Ensembl chr 4:102,501,331...102,617,302
|
|
G |
NOS2 |
nitric oxide synthase 2 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of NOS2 mRNA] AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]] |
CTD |
PMID:24465016 PMID:25108154 |
|
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
|
|
G |
NOS3 |
nitric oxide synthase 3 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid inhibits the reaction [Acetylcholine results in increased phosphorylation of NOS3 protein]] |
CTD |
PMID:25108154 |
|
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of NR0B2 mRNA |
CTD |
PMID:24428821 |
|
NCBI chr 1:26,911,489...26,914,110
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NR1H4 |
nuclear receptor subfamily 1 group H member 4 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of NR1H4 mRNA; AICA ribonucleotide results in decreased expression of NR1H4 protein |
CTD |
PMID:27090119 |
|
NCBI chr12:100,473,866...100,564,414
Ensembl chr12:100,473,708...100,564,414
|
|
G |
NR1I3 |
nuclear receptor subfamily 1 group I member 3 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Phenobarbital results in increased localization of and results in increased activity of NR1I3 protein]; AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]; PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] |
CTD |
PMID:20686344 PMID:22815988 |
|
NCBI chr 1:161,229,666...161,238,623
Ensembl chr 1:161,229,666...161,238,302 Ensembl chr 1:161,229,666...161,238,302
|
|
G |
NRF1 |
nuclear respiratory factor 1 |
multiple interactions increases expression |
ISO |
dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of NRF1 mRNA] |
CTD |
PMID:20438809 |
|
NCBI chr 7:129,611,720...129,757,076
Ensembl chr 7:129,611,720...129,757,082
|
|
G |
OPA1 |
OPA1 mitochondrial dynamin like GTPase |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Acetaminophen results in decreased expression of OPA1 protein]; AICA ribonucleotide inhibits the reaction [Diclofenac results in decreased expression of OPA1 protein] |
CTD |
PMID:27792760 |
|
NCBI chr 3:193,593,149...193,697,811
Ensembl chr 3:193,593,144...193,697,811
|
|
G |
PPARA |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA mRNA]; AICA ribonucleotide inhibits the reaction [Phenylephrine results in decreased expression of PPARA protein] |
CTD |
PMID:19699196 |
|
NCBI chr22:46,150,526...46,243,756
Ensembl chr22:46,150,521...46,243,756
|
|
G |
PPARG |
peroxisome proliferator activated receptor gamma |
multiple interactions |
ISO EXP |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA] AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein] |
CTD |
PMID:25108154 PMID:27688165 |
|
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
|
|
G |
PPARGC1A |
PPARG coactivator 1 alpha |
multiple interactions increases expression decreases expression |
ISO EXP |
dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of PPARGC1A mRNA] AICA ribonucleotide results in decreased expression of PPARGC1A mRNA AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of PPARGC1A protein]; dorsomorphin promotes the reaction [AICA ribonucleotide results in decreased expression of PPARGC1A mRNA] AICA ribonucleotide inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of PPARGC1A protein] |
CTD |
PMID:20438809 PMID:23090186 PMID:24428821 PMID:25522270 |
|
NCBI chr 4:23,792,021...24,472,905
Ensembl chr 4:23,755,041...23,904,089
|
|
G |
PRKAA1 |
protein kinase AMP-activated catalytic subunit alpha 1 |
increases phosphorylation multiple interactions increases expression increases activity |
ISO EXP |
AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of PRKAA1 protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased phosphorylation of PRKAA1 protein]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] AICA ribonucleotide promotes the reaction [Quercetin results in increased phosphorylation of and results in increased activity of PRKAA1 protein]; AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA1 protein; PRKAA1 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA]; Quercetin promotes the reaction [AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA1 protein] AICA ribonucleotide results in increased expression of PRKAA1 protein modified form [AICA ribonucleotide results in increased phosphorylation of PRKAA1 protein] which results in decreased secretion of Progesterone; AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in decreased phosphorylation of PRKAA1 protein]; AICA ribonucleotide inhibits the reaction [Sodium Chloride, Dietary results in decreased phosphorylation of and results in decreased activity of PRKAA1 protein]; AICA ribonucleotide inhibits the reaction [Sodium Chloride, Dietary results in increased expression of PRKAA1 mRNA] AICA ribonucleotide results in increased activity of PRKAA1 protein |
CTD |
PMID:12519745 PMID:16020477 PMID:16873680 PMID:19293639 PMID:20349193 PMID:21195169 PMID:21205922 PMID:23266269 PMID:24465016 PMID:25743752 PMID:28298333 |
|
NCBI chr 5:40,759,379...40,798,195
Ensembl chr 5:40,759,379...40,798,374
|
|
G |
PRKAA2 |
protein kinase AMP-activated catalytic subunit alpha 2 |
multiple interactions increases phosphorylation |
EXP ISO |
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PRKAA2 protein; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CYP4F2 mRNA] PRKAA2 protein promotes the reaction [AICA ribonucleotide promotes the reaction [NR1I3 protein results in increased expression of CYP2B10 mRNA]] AICA ribonucleotide results in increased phosphorylation of PRKAA2 protein PRKAA2 protein affects the reaction [AICA ribonucleotide inhibits the reaction [AKT1 protein mutant form affects the susceptibility to Glucose deficiency]]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 mRNA]; PRKAA2 protein affects the reaction [AICA ribonucleotide results in increased expression of CTNNB1 protein] |
CTD |
PMID:15806154 PMID:16873680 PMID:18482975 PMID:21205922 PMID:21454484 PMID:22815988 |
|
NCBI chr 1:56,645,314...56,715,335
Ensembl chr 1:56,645,314...56,715,335
|
|
G |
PRKCZ |
protein kinase C zeta |
multiple interactions increases activity |
ISO |
1-Butanol inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; Genistein inhibits the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; GRB2 protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein] |
CTD |
PMID:11978788 |
|
NCBI chr 1:2,050,411...2,185,395
Ensembl chr 1:2,050,411...2,185,395
|
|
G |
PTEN |
phosphatase and tensin homolog |
increases response to substance |
EXP |
PTEN protein results in increased susceptibility to AICA ribonucleotide |
CTD |
PMID:19625624 |
|
NCBI chr10:87,863,625...87,971,930
Ensembl chr10:87,863,625...87,971,930
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 protein] |
CTD |
PMID:22025971 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,423 Ensembl chr 1:186,671,791...186,680,423
|
|
G |
PTK2B |
protein tyrosine kinase 2 beta |
multiple interactions |
ISO |
AICA ribonucleotide results in increased phosphorylation of and results in increased activity of PTK2B protein; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of MAPK3 protein]; PTK2B protein affects the reaction [AICA ribonucleotide results in increased activity of PRKCZ protein] |
CTD |
PMID:11978788 |
|
NCBI chr 8:27,311,478...27,459,391
Ensembl chr 8:27,311,482...27,459,391
|
|
G |
RAC1 |
Rac family small GTPase 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased expression of RAC1 protein] |
CTD |
PMID:21195169 |
|
NCBI chr 7:6,374,527...6,403,967
Ensembl chr 7:6,374,527...6,403,967
|
|
G |
RAF1 |
Raf-1 proto-oncogene, serine/threonine kinase |
multiple interactions |
ISO |
RAF1 protein affects the reaction [AICA ribonucleotide results in increased uptake of Deoxyglucose] |
CTD |
PMID:11978788 |
|
NCBI chr 3:12,583,601...12,664,117
Ensembl chr 3:12,583,601...12,664,226 Ensembl chr 3:12,583,601...12,664,226
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Streptozocin results in increased phosphorylation of and results in increased activity of RELA protein] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]]; Niacinamide inhibits the reaction [AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased phosphorylation of RELA protein]] |
CTD |
PMID:22058332 PMID:25108154 |
|
NCBI chr11:65,653,601...65,662,946
Ensembl chr11:65,653,597...65,663,090
|
|
G |
RPS6 |
ribosomal protein S6 |
decreases phosphorylation |
EXP |
AICA ribonucleotide results in decreased phosphorylation of RPS6 protein |
CTD |
PMID:19625624 |
|
NCBI chr 9:19,375,715...19,380,236
Ensembl chr 9:19,375,715...19,380,236
|
|
G |
RPS6KB1 |
ribosomal protein S6 kinase B1 |
multiple interactions decreases phosphorylation increases phosphorylation |
ISO |
AICA ribonucleotide inhibits the reaction [Cadmium Chloride results in increased phosphorylation of RPS6KB1 protein]; naringin inhibits the reaction [AICA ribonucleotide results in increased phosphorylation of RPS6KB1 protein] AICA ribonucleotide results in decreased phosphorylation of RPS6KB1 protein |
CTD |
PMID:15342961 PMID:21195169 PMID:28041982 |
|
NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
|
|
G |
SIRT1 |
sirtuin 1 |
multiple interactions increases expression |
ISO EXP |
[Niacinamide results in decreased activity of SIRT1 protein] which results in decreased susceptibility to AICA ribonucleotide AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein] AICA ribonucleotide results in increased expression of SIRT1 protein AICA ribonucleotide inhibits the reaction [Glucose results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [Streptozocin results in decreased activity of SIRT1 protein]; dorsomorphin inhibits the reaction [AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in decreased expression of SIRT1 protein]]; dorsomorphin inhibits the reaction [AICA ribonucleotide results in increased expression of SIRT1 protein] |
CTD |
PMID:22058332 PMID:23090186 PMID:24465016 PMID:25108154 PMID:27688165 |
|
NCBI chr10:67,884,656...67,918,390
Ensembl chr10:67,884,656...67,918,390
|
|
G |
SLC10A1 |
solute carrier family 10 member 1 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of SLC10A1 mRNA |
CTD |
PMID:27090119 |
|
NCBI chr14:69,775,416...69,797,241
Ensembl chr14:69,775,416...69,797,241
|
|
G |
SLC15A1 |
solute carrier family 15 member 1 |
decreases activity |
EXP |
AICA ribonucleotide results in decreased activity of SLC15A1 protein |
CTD |
PMID:22108913 |
|
NCBI chr13:98,683,801...98,752,672
Ensembl chr13:98,683,801...98,752,672
|
|
G |
SLC2A4 |
solute carrier family 2 member 4 |
multiple interactions increases localization |
ISO |
1-Butanol inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; Genistein inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; U 0126 inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein]; wortmannin inhibits the reaction [AICA ribonucleotide results in increased localization of SLC2A4 protein] AICA ribonucleotide inhibits the reaction [Palmitates results in decreased expression of SLC2A4 mRNA] |
CTD |
PMID:11978788 PMID:21802492 |
|
NCBI chr17:7,281,718...7,288,257
Ensembl chr17:7,281,718...7,288,257
|
|
G |
SLCO1A2 |
solute carrier organic anion transporter family member 1A2 |
decreases expression |
ISO |
AICA ribonucleotide results in decreased expression of SLCO1A2 mRNA |
CTD |
PMID:27090119 |
|
NCBI chr12:21,264,600...21,419,634
Ensembl chr12:21,264,600...21,419,594
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions increases expression |
EXP |
AICA ribonucleotide promotes the reaction [FOXO1 protein results in increased expression of SOD2 mRNA] AICA ribonucleotide results in increased expression of SOD2 mRNA; AICA ribonucleotide results in increased expression of SOD2 protein |
CTD |
PMID:25065674 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529 Ensembl chr 6:159,669,069...159,762,529
|
|
G |
STK11 |
serine/threonine kinase 11 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein] |
CTD |
PMID:27688165 |
|
NCBI chr19:1,205,778...1,228,431
Ensembl chr19:1,177,558...1,228,431 Ensembl chr19:1,177,558...1,228,431
|
|
G |
TBC1D1 |
TBC1 domain family member 1 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D1 protein] |
CTD |
PMID:26627467 |
|
NCBI chr 4:37,891,084...38,139,173
Ensembl chr 4:37,891,084...38,139,175
|
|
G |
TBC1D4 |
TBC1 domain family member 4 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [INS1 protein results in increased phosphorylation of TBC1D4 protein] |
CTD |
PMID:24343960 PMID:26627467 |
|
NCBI chr13:75,283,503...75,483,144
Ensembl chr13:75,283,503...75,482,169
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of MMP13 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of SIRT1 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased phosphorylation of STK11 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of ACTA2 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 protein]; AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein] |
CTD |
PMID:27688165 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TIMP1 |
TIMP metallopeptidase inhibitor 1 |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [TGFB1 protein results in increased expression of TIMP1 protein] |
CTD |
PMID:27688165 |
|
NCBI chr X:47,582,408...47,586,789
Ensembl chr X:47,582,408...47,586,789
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO EXP |
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] AICA ribonucleotide inhibits the reaction [TNF protein promotes the reaction [Oxygen deficiency results in increased expression of GPR68 mRNA]]; AICA ribonucleotide inhibits the reaction [TNF protein results in increased expression of GPR68 mRNA] AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TNF mRNA] |
CTD |
PMID:22025971 PMID:25108154 PMID:28174749 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TNFRSF1A |
TNF receptor superfamily member 1A |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Lipopolysaccharides results in increased expression of TNFRSF1A protein] |
CTD |
PMID:22025971 |
|
NCBI chr12:6,328,771...6,342,076
Ensembl chr12:6,328,757...6,342,114
|
|
G |
TP53 |
tumor protein p53 |
multiple interactions |
EXP |
[resveratrol co-treated with AICA ribonucleotide] inhibits the reaction [Glucose results in increased expression of TP53 protein] |
CTD |
PMID:26188290 |
|
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538 Ensembl chr17:7,661,779...7,687,538
|
|
G |
TXNIP |
thioredoxin interacting protein |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Palmitic Acid results in increased expression of TXNIP protein] |
CTD |
PMID:29031535 |
|
NCBI chr 1:145,992,435...145,996,579
Ensembl chr 1:145,992,435...145,996,579
|
|
G |
UCP2 |
uncoupling protein 2 |
multiple interactions |
ISO |
AICA ribonucleotide inhibits the reaction [Indican results in decreased expression of UCP2 mRNA] |
CTD |
PMID:25703824 |
|
NCBI chr11:73,974,671...73,983,202
Ensembl chr11:73,974,672...73,983,246 Ensembl chr11:73,974,672...73,983,246
|
|
G |
VEGFA |
vascular endothelial growth factor A |
multiple interactions |
EXP |
AICA ribonucleotide inhibits the reaction [[nickel chloride results in increased abundance of Nickel] which results in increased secretion of VEGFA protein] |
CTD |
PMID:30724446 |
|
NCBI chr 6:43,770,209...43,786,487
Ensembl chr 6:43,770,184...43,786,487
|
|
|
G |
PKM |
pyruvate kinase M1/2 |
multiple interactions |
EXP |
Glucose deficiency promotes the reaction [SAICAR binds to and results in increased activity of PKM protein] |
CTD |
PMID:23086999 |
|
NCBI chr15:72,199,029...72,231,389
Ensembl chr15:72,199,029...72,231,822
|
|